NCT05206240

Brief Summary

The aim of this study is to objectively evaluate the effectiveness of radial extracorporeal shock wave therapy (rESWT) and conventional physical therapy program on the gait pattern through a new gait analysis system which encompasses spatiotemporal and kinematic parameters and to correlate the findings with the clinical evaluation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 24, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 25, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

February 16, 2023

Status Verified

February 1, 2023

Enrollment Period

1.3 years

First QC Date

December 24, 2021

Last Update Submit

February 15, 2023

Conditions

Keywords

strokespasticityneurological rehabilitationradial extracorporeal shock wave therapygait analysis system

Outcome Measures

Primary Outcomes (1)

  • Spasticity grade change

    Modified Ashworth Scale (MAS); ranges from 0 (no increase in muscle tone) to 5 (rigid limb in flexion or extension). The lower the score, the lower spasticity grade, thus a better outcome.

    Change from baseline Modified Ashworth Scale at 14 days

Secondary Outcomes (4)

  • Ankle passive range of motion change

    Change from baseline Passive Range of Motion at 14 days

  • Pain intensity change

    Change from baseline Visual Analogue Scale at 14 days

  • Step length change

    Change from baseline step length at 14 days

  • Knee flexion-extension change

    Change from baseline knee flexion-extension at 14 days

Study Arms (1)

Study group

The patients considered eligible will form the study group and will start the conventional physical therapy program and radial extracorporeal shock wave therapy delivery (rESWT).

Other: Radial extracorporeal shock wave therapy and conventional physical therapy

Interventions

The conventional physical therapy program will consist of verticalization strategies, range of motion exercises, muscle stretching and strengthening exercises, stance and balance training, core stability exercises, gait training, functional training, cryotherapy or local heat for 1h/day, 5 days/week for 2 weeks. Regarding the rESWT delivery, 2000 shots will be applied on the triceps surae myotendinous junction with a frequency of 10 Hz and an energy density of 60 mJ, 7 min/session, 1 session/week for 2 weeks.

Study group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Inpatients from the Physical and Rehabilitation Medicine Department stating the eligibility criteria

You may qualify if:

  • suffered from a hemorrhagic or ischemic stroke and they were in the subacute or chronic phase;
  • had no history of previous stroke;
  • had lower limb post- stroke spasticity and spasticity grade ≥1 on the Modified Ashworth Scale (MAS);
  • pain intensity measured on Visual Analogue Scale (VAS) ≥1;
  • ability to stand and walk unassisted for at least 30 seconds;
  • adult patients (\>18 years old).

You may not qualify if:

  • other neurological, musculoskeletal, orthopaedic, or cardiovascular conditions; -- severe cognitive impairment, severe aphasia or inability to understand or execute instructions;
  • changes in antispastic medication and dose or changes in the analgesic medication;
  • myopathy;
  • severe spasticity grade;
  • visual field disorders or hemineglect;
  • anticoagulants or any contraindication to receive radial extracorporeal shock wave therapy (rESWT), or any contraindication to receive physical therapy sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elias University Emergency Hospital

Bucharest, Romania

Location

MeSH Terms

Conditions

Ischemic StrokeHemorrhagic StrokeMuscle SpasticityGait Disorders, NeurologicStroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mihai Berteanu

    Elias University Emergency Hospital, Bucharest, Romania

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 24, 2021

First Posted

January 25, 2022

Study Start

March 1, 2021

Primary Completion

June 1, 2022

Study Completion

August 1, 2022

Last Updated

February 16, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations